TrialJournal of psychopharmacology (Oxford, England)2026

A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder.

Francisco A Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.